Company Details
| Sector | PHARMACEUTICALS |
| Address | 35 - Dockyard Road West Wharf Karachi |
| Auditor | Yousuf Adil, Chartered Accountants |
| Registrar | CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi |
| Website | www.pk.gsk.com |
| Fiscal Year | December |
| Details |
Details
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V.@ incorporated in Netherlands@ whereas its ultimate parent company is GlaxoSmithKline plc@ UK (GSK plc).
Company Announcements
| Date/Time | Announcement |
|---|---|
| 25/02/2015 15:51:50 | BOOK CLOSURE FROM 16/04/2015 FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2014 DIVIDEND = 50% PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,848.582 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,687.071 EPS = 5.30 ANNUAL GENERAL MEETING WILL BE HELD ON 23/04/2015 BOOK CLOSURE TO 23/04/2015 |
| 21/10/2014 15:55:23 | EPS = 3.75 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,022.665 FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2014 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,192.665 |
| 22/08/2014 15:11:37 | PROFIT/LOSS AFTER TAXATION RS. IN MILLION 792.670 FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2014 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,303.182 EPS = 2.49 |
| 28/04/2014 11:57:36 | FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2014 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 797.948 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 484.848 EPS = 1.67 |
| 07/02/2014 15:24:14 | FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2013 DIVIDEND = 35% BONUS ISSUE = 10% PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,809.872 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,062.263 EPS = 3.67 ANNUAL GENERAL MEETING WILL BE HELD ON 28/04/2014 BOOK CLOSURE FROM 21/04/2014 BOOK CLOSURE TO 28/04/2014 |